Vedana Therapeutics launches to develop migraine therapies
Memento Medicines launches with $93m to develop antibody therapy for retinal diseases
Meteor Biotech joins brain organoids consortium
Can food influence gene activity?
Restoring the “longevity protein”
Positive topline results from phase 2 recurrent ovarian cancer trial
Rare oral cancer has distinct genetic profile
New tool decodes structures and motifs of RNA
Elite immune cells lead fight against multiple myeloma
National framework to strengthen UK advanced therapy clinical trials
Sensor detects Alzheimer’s and Parkinson’s in blood
Base to Base biotech podcast 60: Delivery method reduces prostate cancer tumour size